@ASPIRE_CoP
 United States
Joined April 2025
  • Tweets162
  • Following49
  • Followers148
29Media
🎉 Big news! The new ASPIRE Special Interest Group at #SITC26 holds its first in-person meet-up. 📅 Nov 7, 7:10–7:40 PM at the SITC booth in Phoenix. 🌵 Come connect, share ideas & help build the SIG. Appetizers & drinks on us! 🍽️ #irAE #immunotherapy @KMittalmd @sitcancer
2
2
323
📚 Reading recs from ASPIRE: • First-line FMT for ICI colitis: ~77% improved, symptoms resolved in a median of 1.5 days • Recurrent ICI arthritis: the same infl T cells in first and later flares Links 👉 pubmed.ncbi.nlm.nih.gov/4273… pubmed.ncbi.nlm.nih.gov/4253… #irAE #immunotherapy

First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-med...

Immune checkpoint inhibitor (ICI) therapy commonly leads to adverse events such as ICI-mediated diarrhea and colitis (IMDC). Fecal microbiota transplantation (FMT) remains an option for patients with...

pubmed.ncbi.nlm.nih.gov
1
2
66
ASPIRE Community of Practice retweeted
Annie Wong 黃毅敏@anmwongNZOct 2
Drs Andrew Trinh and Sophia Ling are fantastic gastroenterology colleagues @PeterMacCC Thanks so much for helping @NzsOncology put together this free irAE webinar series 🤩 great resource! @MOGA_ORG @ONCOassist @OncoAlert @ASPIRE_CoP @IndianYoungOnco @oncodaily
NZSOncology@NzsOncologyOct 1
The latest of our #NZSOimmunotoxwebinar series is now available online as a FREE resource for any to use and reference! Share widely amongst colleagues 👉nzsoncology.org.nz/webinarse…
1
4
13
450
ASPIRE, a community of practice of @ASCO is proud to present a virtual webinar on Elevating Patient Voices in the Management of irAEs. Join us today at 4 pm EST for our Quarterly Webinar series with hosts @KMittalmd and @afreenshariffmd 🔗 in flyer ⬇️
ASPIRE Community of Practice@ASPIRE_CoPSep 10
📢 ASPIRE Quarterly Webinar Elevating Patient Voices & Management of #irAEs 📆 Tues 9/22 · 4:00–5:30 PM ET 🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos 🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd 💻 Zoom🔗: us.list-manage.com/1B14TXB1R… #Oncology
1
2
147
📢 ASPIRE Quarterly Webinar Elevating Patient Voices & Management of #irAEs 📆 Tues 9/22 · 4:00–5:30 PM ET 🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos 🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd 💻 Zoom🔗: us.list-manage.com/1B14TXB1R… #Oncology
1
1
2
318
Residents & fellows: how are you learning about immune-related adverse events? ⏱️ 5 minutes 🔒 Anonymous ✅ No right or wrong answers Help ASPIRE's Community Education Committee build better irAE education 👇
1
2
6
833
🚨 Aug 18: ASPIRE case discussion on immunotherapy toxicity 🧠 Neuro — John Probasco, MD (Hopkins) 🩹 Skin — Silvina Pugliese, MD (NYU) Moderators: Aliyah Pabani, MD & Stephane Champiat, MD, PhD 5:30–6:30 PM CST | CME 51508 tinyurl.com/yck5afku #irAE #Oncology @KMittalmd
1
1
1
1
1,176
In case you missed this- link will be in our upcoming newsletter- stay tuned!
17
ASPIRE Community of Practice retweeted
KMittaloncMD@KMittalmdAug 21
Replying to @ASPIRE_CoP
@ASPIRE_CoP members please take note!
Pauline Funchain@FunchainMDAug 21
🚨irAE aficianados! Open comment for Renal, Musculoskeletal, and Cardiac adverse events sections of the @ASCO irAE guidelines are now available through August 28th at: asco1.qualtrics.com/jfe/form… As everything with irAE, it's a team sport. We want to hear your comments!
1
1
309
Please share with your trainees- to help us design evidence based education pertaining to irAEs. cc: @DrKarineTawagi @ASridharMD @NazliDizman @FunchainMD @PGrivasMDPhD
KMittaloncMD@KMittalmdJun 15
Link for #irAE trainee survey 👇 arcsapps.umassmed.edu/redcap… @HemOncFellows @hemeoncfellow
2
1
5
1,640
Happening now- join us for our quarterly webinar!
2
119
⏰ Starting in 15 minutes! Join ASPIRE's webinar "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" — 4 PM EST with our expert panel. Hop on 👉 shorturl.at/B2zt2 #irAE #immunotherapy #oncology

Join our Cloud HD Video Meeting

Zoom is the leader in modern enterprise cloud communications.

mgb-org.zoom.us
2
84
Glad to see some of our Executive Committee members on this- @ASPIRE_CoP remains committed to fostering a community of #irAE clinicians, educators and researchers! @FunchainMD @thenasheffect
Alessio Cortellini@ACortelliniMDJun 16
Today's @sitcancer program on immunotherapy toxicity management felt less like a webinar and more like a conversation among colleagues. #irAEs remain one of the areas where clinical experience is often ahead of the evidence, making discussions like these particularly valuable. A pleasure to share the session with such a great faculty panel and many friends across the field. @kreynoldsMD @thenasheffect @EladSharonMD @FunchainMD @LKottschadeCNP Ryan Sullivan, Matthew Lei, Aleksandra Kukla. Thanks to @sitcancer for the invitation and the discussion! @Surgeon_General @CampusBioMedico @PoliclinCampus
1
1
4
463
Here’s a 🔗 to the newsletter mailchi.mp/1e6c4c8aed14/f9hi… Don’t forget to log in for our June 17 ASCO irAE webinar!
ASPIRE Community of Practice@ASPIRE_CoPJun 16
📬 The latest ASPIRE June Newsletter is here! Inside: our back by popular-demand curated #irAE abstracts list, #ASCO26 meeting highlights & more. ⭐ Don't miss our June 17 webinar — "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" 4 PM EST with an expert panel
1
2
390
📬 The latest ASPIRE June Newsletter is here! Inside: our back by popular-demand curated #irAE abstracts list, #ASCO26 meeting highlights & more. ⭐ Don't miss our June 17 webinar — "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" 4 PM EST with an expert panel
2
1
2
311
ASPIRE Community of Practice retweeted
KMittaloncMD@KMittalmdJun 15
Link for #irAE trainee survey 👇 arcsapps.umassmed.edu/redcap… @HemOncFellows @hemeoncfellow
ASPIRE Community of Practice@ASPIRE_CoPJun 11
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
4
1
5
2,701
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
ASPIRE Community of Practice@ASPIRE_CoPMay 11
📢 Residents & Fellows: Help shape the future of immunotherapy education! Participate in our 5-min anonymous survey on #irAE experiences.🩺 Program directors and faculty—please share with your trainees! Complete the survey:🔗 shorturl.at/GMNMY #ASPIRECOP #OncMedEd
1
4
2,318
Couldn't catch every #irAE session at #ASCO26? We've got you! 🧡 Join @ASPIRE_CoP, @FunchainMD, @mhadfield30, @LZubiriOteiza & Dr. Pabani for ASPIRE's post-ASCO webinar 📅 June 17, 4 PM EST Free to join 👉shorturl.at/B2zt2 #immunotherapy
1
2
1
3
1,301
ASPIRE Community of Practice retweeted
Pauline Funchain@FunchainMDJun 4
🚨irAE aficianados! Help shape @ASCO guidelines in part 1 of open comment on the next iteration of ASCO's irAE guidelines. Open for comment until Wed 6/10 ✍️ Part 1: 🫁👁️👄 Link to comment here 👇 asco1.qualtrics.com/jfe/form…
1
6
18
954
Live at #ASCO26: "Advancing ICI Therapy in High-Risk Populations" — rechallenge, transplant & combo toxicity. 📍E450a 🕖 4:45 - 6:00 PM CDT Takeaway: @MattCarlino  #immunotherapy #irAE
1
1
1
2
504
Load more